P
RTO icon

&Partners’s Rentokil RTO Stock Holding History

&Partners’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$648K Buy
22,683
+3,456
+18% +$110K ﹤0.01% 1681
2026
Q1 		$605K Buy
19,227
+5,820
+43% +$183K ﹤0.01% 1594
2025
Q4 		$395K Buy
+13,407
New +$372K ﹤0.01% 1754
2024
Q4 		– Sell
-10,470
Closed -$261K – 1671
2024
Q3 		$261K Buy
10,470
+2,513
+32% +$74.4K 0.01% 1179
2024
Q2 		$236K Buy
+7,957
New +$221K 0.01% 794

Other funds holding RTO

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SL
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

&Partners's RTO Position: Q2 2026 in Review

&Partners increased its Rentokil (RTO) stake by 18% in Q2 2026, buying an estimated $110K and bringing the position to 22,683 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

&Partners first reported a position in RTO in Q2 2024 and has held it in 5 quarters since. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • &Partners held 22,683 shares of Rentokil worth $648K as of Q2 2026.
  • &Partners bought 3,456 Rentokil shares in Q2 2026, an estimated $110K.
  • Rentokil made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1681 holding.
  • &Partners first reported a position in Rentokil in Q2 2024 and has held it in 5 quarters since.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.